Security key
799566104
Sana Biotechnology, Inc. - Common Stock, $0.0001 par value per share (SANA)
CUSIP: 799566104
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 31,550
- Total 13F value
- $110,110
- Share change
- -4,472
- SEC-reported price per share
- $3.49
- Number of holders
- 2
- Value change
- -$15,472
- Number of sells
- 2
- Shares outstanding
- 297,619,048
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
2
Top holders
2
SANA full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Sana Biotechnology, Inc. SEC filings
Sana Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 799566104
Recent filing periods:
Ownership snapshot
Top reported holders of SANA - Sana Biotechnology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARCH Venture Fund IX, L.P.
Disclosed value leader
ARCH Venture Fund IX, L.P.
Comparable rows
15/15
Latest evidence
14 May 2026
13D/G
13F
3/4/5
Lead comparable stake: 17%
13D/G row: ARCH Venture Fund IX, L.P.
Showing 1-6 of 15 holder rows.
Quick read
ARCH Venture Fund IX, L.P. leads the comparable SEC ownership view at 17%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARCH Venture Fund IX, L.P.'s linked filing trail.
Comparable ownership
Top 5
ARCH Venture Fund IX, L.P.
17%
RA CAPITAL MANAGEMENT, L.P.
6.3%
BlackRock, Inc.
5.1%
VANGUARD GROUP INC
4.8%
Dhavalkumar Dhirajlal Patel
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P. |
13D/G
Robert Nelsen
|
17%
|
$163,630,594
46,093,125 shares
|
$0 | 30 Sep 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
6.3%
|
$61,125,000
18,750,000 shares
|
$0 | 14 May 2026 |
| BlackRock, Inc. |
13D/G
13F
Company
|
5.1%
|
$55,528,247
13,643,304 shares
|
+$10,647,588 | 31 Dec 2025 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
4.8%
|
$19,023,535
10,747,760 shares
|
$0 | 31 Dec 2024 |
| Dhavalkumar Dhirajlal Patel |
3/4/5
EVP, Chief Scientific Officer
|
0.03%
|
$405,005
99,510 shares
|
— | 24 Mar 2026 |
| FMR LLC |
13F
3/4/5
Company · Other*, 10%+ Owner
|
13%
|
$107,799,219
37,430,284 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
31,550
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
201
Q2 2026 holders
2
Holder diff
-199
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend